The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, ...
Huxley Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and commercial release of central sleep apnea (CSA) detection for its SANSA® home sleep apnea test.
Edmonton, AB – December 22, 2025 – PRESSADVANTAGE – A first in western Canada, access to TIER-1 ENDOSURE testing for the ...
Experts predict a test measuring p-tau217 in blood plasma may become a standard screening tool for Alzheimer’s disease in ...
The blood test also had a sensitivity and specificity of 92.3% and 92.6% for participants who do not have breast cancer. The results were consistent for women with dense breast tissue and non-dense ...
Canada: A large international study of febrile infants aged 28 days or younger presenting to emergency departments has found ...
A self-referral tool for patients with chronic back pain may be a feasible solution for identifying axial spondyloarthritis, ...
numares Health enters ASEAN region with regulatory approval in Malaysia and first contract win for AXINON (R) LDLp Test System -- AXINON (R) LDLp Test System receives Medical Device Authority (MDA) in ...
Florian Voss, Chief Executive Officer at numares Health said: "Malaysia is a known leader in innovation in the ASEAN region and their swift approval and adoption of the AXINON® LDLp Test System ...
Triage Plus was designed to detect mRNAs and DNA single-nucleotide variants from fibroblast growth factor receptor 3 and telomerase reverse transcriptase genes associated with bladder cancer.
Evvy’s new UTI+ Test and microbiome tools deliver faster, clearer insights into BV and UTI care, reshaping women’s health with precision diagnostics ...
Over the past decade, earning an ophthalmology residency spot has become more difficult and competitive. 1 Between 2021 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback